Editorial comment on "Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain".

Published in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2023)

Keyphrases